Media Centre
Latest press releases
-
AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
-
Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
-
Voydeya recommended for approval in the EU by CHMP as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia
-
Acquisition of Gracell completed
-
Acquisition of Icosavax Completed
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.